Arrowstreet Capital, Limited Partnership Bristol Myers Squibb CO Transaction History
Arrowstreet Capital, Limited Partnership
- $148 Billion
- Q3 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 14,833,977 shares of BMY stock, worth $694 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
14,833,977
Previous 11,311,281
31.14%
Holding current value
$694 Million
Previous $524 Million
27.77%
% of portfolio
0.45%
Previous 0.39%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...